SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 6-K

 

 

REPORT OF A FOREIGN ISSUER

PURSUANT TO RULE 13A-16 OR 15D-16

OF THE SECURITIES EXCHANGE ACT OF 1934

For January 13, 2020

Commission File Number 1-38455

 

 

MorphoSys AG

 

 

Semmelweisstrasse 7

82152 Planegg

Germany

(Address of principal executive offices)

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F  ☒            Form 40-F  ☐

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes  ☐            No  ☒

If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b):

EXHIBIT 99.1 TO THIS REPORT ON FORM 6-K IS INCORPORATED BY REFERENCE IN THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-226422) OF MORPHOSYS AG AND IN THE OUTSTANDING PROSPECTUS CONTAINED IN SUCH REGISTRATION STATEMENT.

 

 

 



SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

    MORPHOSYS AG (Registrant)
Date: January 13, 2020     By:  

/s/ Dr. Sarah Fakih

    Name:   Dr. Sarah Fakih
    Title:   Vice President | Head of Corporate Communications & IR

 

    By:  

/s/ Dr. Verena Kupas

    Name:   Dr. Verena Kupas
    Title:  

Associate Director

Corporate Communications and Investor Relations

MorphoSys (PK) (USOTC:MPSYF)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more MorphoSys (PK) Charts.
MorphoSys (PK) (USOTC:MPSYF)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more MorphoSys (PK) Charts.